Research report on anti-HBV drug market

Date: July 22, 2009
Pages: 8
Price:
US$ 400.00
Publisher: SunFaith China Ltd.
Report type: Brief Review
Delivery: E-mail Delivery (PDF)
ID: RD6B2270503EN
Leaflet:

Download PDF Leaflet

Research report on anti-HBV drug market
Under the joint impact of four anti-HBV nucleoside drugs, i.e. lamivudine, adefovir dipivoxil, entecavir and Telbivudine, from 2001~2006, anti-HBV market of China’s sample hospitals in key cities grew at a speed of more than average 30%. It is no doubt that China’s anti-HBV drug will continue to develop rapidly in a period of time in the future. This report mainly classifies the current anti-HBV drugs, and analyzes the most important types of anti-HBV drug markets and demand markets.
1. BRIEF INTRODUCTION AND CLASSIFICATION OF ANTI-HBV DRUG

2. SCALE ANALYSIS OF ANTI-HBV DRUG MARKET

3. ANTI-HBV-VIRUS TYPE HBV TREATMENT DRUG

4. IMMUNE REGULATION TYPE HBV TREATMENT DRUG

5. HBV TREATMENT DRUG THAT IMPROVE LIVER CELL FUNCTION

6. DEMAND MARKET ANALYSIS OF ANTI-HBV DRUG
Skip to top


Anti-Migraine Drugs: Market Research Report US$ 3,950.00 Feb, 2010 · 580 pages
Anti-Hypertensive Drugs: Market Research Report US$ 3,950.00 Feb, 2010 · 893 pages
Research Report on Chinese Anti-Tumor Drug Market, 2009 US$ 1,160.00 Mar, 2009 · 60 pages
Anti-Tumor Drugs Market Research (China) US$ 4,000.00 May, 2016 · 214 pages
Anti-Obesity Drugs: Market Research Report US$ 4,950.00 Jan, 2014 · 135 pages

Ask Your Question

Research report on anti-HBV drug market
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: